Here's Why the Post-Pandemic World May Be Even Better for This Vaccine Maker
Moderna (NASDAQ: MRNA) is the name behind one of last year's top-selling pharmaceutical products. Does that mean Moderna's sales will plunge? In fact, Moderna's best days may not be in the past -- but in the future.